Late-onset endometrial ablation failure

Morris Wortman, Morris Wortman

Abstract

Endometrial ablation, first reported in the 19th century, has gained wide acceptance in the gynecologic community as an important tool for the management of abnormal uterine bleeding when medical management has been unsuccessful or contraindicated. The introduction of global endometrial ablation (GEA) devices beginning in 1997 has provided unsurpassed safety addressing many of the concerns associated with their resectoscopic predecessors. As of this writing the GEA market has surpassed a half-million devices in the United States per annum and has an expected compound annual growth rate (CAGR) projected to be 5.5% from 2016 to 2024. While the short term safety and efficacy of these devices has been reported in numerous clinical trials we only recently are becoming aware of the high incidence of late-onset endometrial ablation failures (LOEAFs) associated with these procedures. Currently, about a quarter of women who undergo a GEA procedure will eventually require a hysterectomy while an unknown number have less than satisfactory results. In order to reduce these suboptimal outcomes physicians must better understand the etiology and risk factors that predispose a patient toward the development of LOEAF as well as current knowledge of patient and procedure selection for EA as well as treatment options for these delayed complications.

Figures

Fig. 1
Fig. 1
Bardenheuer's Kungelsondenelktrode.
Fig. 2
Fig. 2
Hysteroscopic endometrial laser ablation.
Fig. 3
Fig. 3
Hysteroscopic endometrial ablation with the “ball-end” electrode.
Fig. 4
Fig. 4
Thermal Balloon System (ThermaChoice).
Fig. 5
Fig. 5
Cryoendometrial ablation (Her Option).
Fig. 6
Fig. 6
Heated Free-Fluid System (Hydro ThermAblator).
Fig. 7
Fig. 7
Bipolar Radiofrequency ablation device (NovaSure).
Fig. 8
Fig. 8
Microwave ablation system (MEA System).
Fig. 9
Fig. 9
Radiofrequency ablation (Minerva).
Fig. 10
Fig. 10
Global endometrial ablation devices in the U. S. – Market share by device.
Fig. 11
Fig. 11
Sonographic view of failed GEA procedure demonstrating small bilateral cornual hematometra.
Fig. 12
Fig. 12
Sonographic view of failed GEA procedure demonstrating large and asymmetrical cornual hematometra.
Fig. 13
Fig. 13
a, b Sonographic and hysteroscopic view of endometrial growth following a GEA procedure in the presence of a uterine septum.
Fig. 14
Fig. 14
Ultrasound-Guided Reoperative Hysteroscopic Surgery (UGRHS).
Fig. 15
Fig. 15
An intramural leiomyoma is unroofed and removed during the course of UGRHS.
Fig. 16
Fig. 16
a – h Dissection sequence of UGRHS in a woman with a cyclic left lower quadrant pain and abundant endometrium at the left cornua.
Fig. A1
Fig. A1
The posterior distal lower segment has been removed enabling the continuous flow of distention fluid. The resectoscope, at this point, is just beyond the internal cervical os.
Fig. A2
Fig. A2
Visualization of the left hemi-uterus.
Fig. A3
Fig. A3
The right lateral wall has been removed in order to facilitate distention of the uterine cavity. Endometrial growth is seen along the left cornual region as well as the uterine fundus.
Fig. A4
Fig. A4
Close-up of left cornua.
Fig. A5
Fig. A5
In this view we can appreciate that the left cornua is quite deeply recessed. This suggests that there may have been a uterine septum at the outset.
Fig. A6
Fig. A6
In addition to an excellent view of the left cornua, and some remaining endometrium, the patient’s right side reveals some evidence of adenomyosis as endometrium is interlaced with myometrial tissue.
Fig. A7
Fig. A7
This is a panoramic view of the uterine fundus in the midline after much of the left cornua has been resected. Note some hemosiderin stained tissue at the patient’s right and some adenomyosis at the fundus in the center.
Fig. A8
Fig. A8
After exploring the hemosiderin stained tissue to the right of midline some addition endometrium appears to have been uncovered.
Fig. A9
Fig. A9
Further exploration of the right side is performed and an area of sequestration is noted toward the right cornua. At first glance this appears to be a uterine perforation. However, sonographic guidance reassures us at all times.
Fig. A10
Fig. A10
Greater detail of the right cornua with abundant endometrial growth.
Fig. A11
Fig. A11
Return to left cornua for inspection.
Fig. A12
Fig. A12
Further dissection into left cornua reveals additional endometrial elements. Simultaneous ultrasound guidance reveals that the sero-muscular thickness at the left cornua is 4 mm.
Fig. A13
Fig. A13
Return to inspect right cornua. No evidence of endometrial growth.
Fig. A14
Fig. A14
Deep coagulation of the right cornua with a roller barrel electrode at 120 watts.
Fig. A15
Fig. A15
Deep coagulation of remaining endometrial elements at the left cornua.
Fig. A16
Fig. A16
Panoramic view of left cornua.
Fig. A17
Fig. A17
Panoramic view of right cornua.

References

    1. Leape LL, Bernstein SJ, Bohon CJ, Dickerson VM, Ling FW, Shiffman RN, Kanouse DE. Hysterectomy: Clinical Recommendations and Indications for Use. Southern California Health Policy Research Consortium. RAND.
    1. Wright J.D., Herzog T.J., Tsui J., Ananth C.V., Lewin S.N., Lu Y.S., Neugut A.I., Hershman D.L. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet. Gynecol. 2013;122:233–241.
    1. Munro M.G. ACOG practice bulletin: endometrial ablation. Obstet. Gynecol. 2007;109:1233–1247.
    1. Longinotti M.K., Jacobson G.F., Hung Y.Y., Learman L.A. Probability of hysterectomy after endometrial ablation. Obstet. Gynecol. 2008;112:1214–1220.
    1. Sharp J.T. Endometrial ablation: postoperative complications. Am. J. Obstet. Gynecol. 2012;207:242–247.
    1. McCausland A.M., McCausland V.M. Long-term complications of endometrial ablation: cause, diagnosis, treatment and prevention. J. Minim. Invasive Gynecol. 2007:399–406.
    1. Dührssen . No. 36. Berliner klin; Wochenschrift: 1898. Steam in the Treatment of Uterine Hemorrhage.
    1. Massarweh N.N., Cosgriff N., Slakey D.P. Electrosurgery: history, principles and current and future uses. J. Am. Coll. Surg. 2006;202:520–530.
    1. Bardenheuer F.H. Elextrokoagulation der Uterusschleimhaut zur behandlung klimakterischer blutungen. Zbl. Gynakol. 1937;4:209–211.
    1. Baumann A. Electrocoagulation of endometrium and cervical mucosa (for uterine hemorrhage and leakorrhea) Gerburtshilfe Frauenheilkd. 1948;8:221–226. [in German]
    1. Schmitz H. Radium in gynecology. Radium. 1917;9(1):8–12.
    1. Aikins W.H.B. Canadian Practitioner and Review. 1919. The value of radium in curing disease, in prolonging life, and in alleviating distressing symptoms. ISBN 0665759800. Toronto CA.
    1. Schulze M. Menorrhagia: the results of radium treatment—a follow-up study. Cal. West Med. 1937;47:101–106.
    1. Cahan W., Brockunier A. Cryosurgery of the uterine cavity. Am. J. Obstet. Gynecol. 1967;99:138–153.
    1. Droegemueller W., Greer B., Makowski E. Cryosurgery in patients with dysfunctional bleeding. Obstet. Gynecol. 1971;38:256–258.
    1. Goldrath M.H., Fuller T.A., Segal S. Laser photovaporization of the endometrium for treatment of menorrhagia. Am. J. Obstet. Gynecol. 1981;140:14–19.
    1. DeCherney A., Polan M.L. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet. Gynecol. 1983;61:392–397.
    1. Iglesias J.J., Sporer A., Gellman A.C., Seebode J.J. New Iglesias resectoscope with continuous irrigation, simultaneous suction and low intravesical pressure. J. Urol. 1975;114:929–933.
    1. Brooks P.G., Loeffer F.D., Serden S.P. Resectoscopic removal of symptomatic intrauterine lesions. J. Reprod. Med. 1989;34:435–437.
    1. Vancaillie T.G. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet. Gynecol. 1989;74:425–427.
    1. Townsend D.E., Richart R.M., Paskowitz R.A., Woolfork R.E. “Rollerball” coagulation of the endometrium. Obstet. Gynecol. 1990;76:310–313.
    1. Arieff A.I., Ayus J.C. Endometrial ablation complicated by fatal hyponatremic encephalopathy. JAMA. 1993;370:1230–1232.
    1. Baggish M.S., Brill A.I., Rosensweig Barbot J.I., Indman P.D. Fatal acute glycine and sorbitol toxicity during operative hysteroscopy. J. Gynecol. Surg. 2009;9:137–143.
    1. Daniels J.P. The long-term outcomes of endometrial ablation in the treatment of heavy menstrual bleeding. Curr. Opin. Obstet. Gynecol. 2013;25:320–326.
    1. Glazerman L.R. Endometrial ablation as treatment of heavy menstrual bleeding. Surg. Technol. Int. 2013;23:137–141.
    1. Glasser M.H., Heinlein P.K., Hung Y.Y. Office endometrial ablation with local anesthesia using the HydroThermAblator system: comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5½ years. J. Minim. Invasive Gynecol. 2009;16:700–707.
    1. Kalkat R.K., Cartmill R.S. NovaSure endometrial ablation under local anesthesia in an outpatient setting: an observational study. J. Obstet. Gynaecol. 2011;31:152–155.
    1. . Queried May 27, 2017.
    1. U. S. benign uterine conditions therapy systems market. Report #A470. Bedminster, NJ: Elsevier Business Intelligence. Exhibit 1-3 Page 1-14.
    1. Endometrial Ablation Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016-2024. Transparency Market Research, Ltd; February 2017.
    1. Parker P.M. ICON Group International, Inc.; Las Vegas, NV: 2017. The 2018-23 World Outlook for Endometrial Ablation Devices.
    1. Whiteman M.K., Hillis S.D., Jamieson D.J., Morrow B. Inpatient hysterectomy surveillance in the United States 2000–2004. J. Obstet. Gynecol. 2008;198(1):e1–34.e7.
    1. Taskin O., Onoglu A., Inal M. Long-term histopathologic and morphologic changes after thermal endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 2002;9:186–190.
    1. Onoglu A., Taskin O., Inal M. Comparison of the long-term histopathologic and morphologic changes after endometrial rollerball ablation and resection: a prospective randomized trial. J. Minim. Invasive Gynecol. 2007;14:39–42.
    1. Shavell V.I., Diamond M.P., Senter J.P., Kruger M.L., Johns A.D. Hysterectomy subsequent to endometrial ablation. J. Minim. Invasive Gynecol. 2012;19:459–464.
    1. Vilos G.A., Abu-Rafea B., Etler H.C., Ahmad R. Indications for hysterectomy and uterine histopathology following hysteroscopic endometrial ablation. J. Minim. Invasive Gynecol. 2005;12:S9.
    1. Wortman M., Daggett A. Reoperative hysteroscopic surgery in the management of patients who fail endometrial ablation and resection. J. Am. Assoc. Gynecol. Laparosc. 2001;8:272–277.
    1. Ahonkallio S.J., Liakka A.K., Martinkainen H.K. Feasibility of endometrial assessment after thermal ablation. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009;147:69–71.
    1. Wortman M., Daggett A., Deckman A. Ultrasound-guided reoperative hysteroscopy for managing global endometrial ablation failures. J. Minim. Invasive Gynecol. 2014;21:238–244.
    1. Lethaby A., Penninx J., Hickey M., Garry R. Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2013;8(20) (Cochrane Collaboration. John Wiley & Sons, Ltd.)
    1. Tresserra F., Grasers P., Ubeda A., Pascual M.A. Morphological changes in hysterectomies after endometrial ablation. Hum. Reprod. 1999;14:1473–1477.
    1. Simon R.A., Quddus M.R., Lawrence W.D., Sung C.J. Pathology of endometrial ablation failures: a clinicopathologic study of 164 cases. Int. J. Gynecol. Pathol. 2015;34:245–252.
    1. Lisa J.R., Gioia J.D., Rubin I.C. Observations of the interstitial portion of the fallopian tube. Surg Gynecol Obstet. 1954;92:159–169.
    1. Turnbull L.W., Bowsley S.J., Horsman A. Magnetic resonance imaging of the uterus after endometrial resection. Br. J. Obstet. Gynaecol. 1997;104:934–938.
    1. Riley KA, Davies MF, Harkins GJ. Characteristics of patients undergoing hysterectomy for failed endometrial ablation. JSLS. 1013; 17:503–7.
    1. Seidman J.D., Kjerulff K.H. Pathologic findings from the Maryland Women’s Health Study: practice patterns in the diagnosis of adenomyosis. Int. J. Gynecol. Pathol. 1996;15:217–221.
    1. McCausland A.M., McCausland V.M. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am. J. Obstet. Gynecol. 1996;174:1793–1794.
    1. Wortman M., Daggett A. Hysteroscopic endomyometrial resection. JSLS. 2000;4:197–207.
    1. Gemer O., Kruchkovich J., Huerta M., Kapustian V. Perioperative predictors of successful hysteroscopic endometrial ablation. Gynecol. Obstet. Invest. 2007;63:205–208.
    1. Hachmann-Nielsen E., Rudnicki M. Clinical outcome after hydrothermal ablation treatment of menorrhagia in patients with and without submucous myomas. J. Minim. Invasive Gynecol. 2012;19:212–216.
    1. Magos A., Baumann R., Lockwood G.M., Turnbull A.C. Experience with the first 250 endometrial resections for menorrhagia. Lancet. 1991;337:1074–1080.
    1. Hopkins M.R., Creedon D.J. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J. Minim. Invasive Gynecol. 2007;104:934–938.
    1. Townsend D.E., McCausland V., McCausland A., Fields G., Kauffman K. Post-ablation tubal sterilization syndrome. Obstet. Gynecol. 1993;82:422–424.
    1. El-Nashar S.A., Hopkins M.R., Creedon D.J. Prediction of treatment outcomes after global endometrial ablation. Obstet. Gynecol. 2009;113:97–106.
    1. Copperman A.B., DeCherney A.H., Olive D.L. A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding. Obstet. Gynecol. 1993;82:640–642.
    1. Margolis M.T., Thoen L.D., Boike G.M., Mercer L.J., Keith L.G. Asymptomatic endometrial carcinoma after endometrial ablation. Int. J. Gynecol. Obstet. 1995;51:255–258.
    1. AlHilli M.M., Hopkins M.R., Famuyide A.O. Endometrial cancer after endometrial ablation: systematic review of the medical literature. J. Minim. Invasive Gynecol. 2011;18:394–400.
    1. Wortman M., Dawkins J.C. Post-ablation Endometrial Carcinoma (PAEC) following radiofrequency endometrial ablation: a case report and its implications for management of endometrial ablation failures. Surg. Technol. Int. 2016;XXIX:161–166.
    1. Wortman M., Vilos G.A., Vilos A.G., Abu-Rafea A., Dwyer W.A. Post-ablation endometrial carcinoma: additional case reports and literature review. JSLS. 2017 (In Print)
    1. Neuwirth R.S., Loffer F.D., Trenhaile T. The incidence of endometrial cancer after endometrial ablation in a low-risk population. J. Am. Assoc. Gynecol. Laparosc. 2004;11:492–494.
    1. . Queried May 28, 2017.
    1. Krogh R.A., Lauszus F.F., Guttorm E., Rasmussen K. Surgery and cancer after endometrial resection. Long-term follow-up on menstrual bleeding and hormone treatment by questionnaire and registry. Arch. Gynecol. Obstet. 2009;280:911–916.
    1. Singh M., Hosni M.M., Jones S.E. Is endometrial ablation protective against endometrial cancer? A retrospective observational study. Arch. Gynecol. Obstet. 2016;293:1033–1037.
    1. Dutton C., Ackerson L., Phelps-Sandall B. Outcomes after rollerball endometrial ablation for menorrhagia. Obstet. Gynecol. 2001;98:35–39.
    1. Istre O., Langebrekke A. Repeat hysteroscopic surgery reduces hysterectomy rate after endometrial and myoma resection. J. Am. Assoc. Gynecol. Laparosc. 2003;10:247–251.
    1. Comino R., Torrejon R. Hysterectomy after endometrial ablation-resection. J. Am. Assoc. Gynecol. Laparosc. 2004;11:495–499.
    1. Kreider S.E., Starcher R., Hoppe J., Nelson K. Endometrial ablation: is tubal ligation a risk factor for hysterectomy? J. Minim. Invasive Gynecol. 2013;209:611–619.
    1. Shazly S.A., Famuyide A.O., El-Nashar S.A., Breitkmopt D.M. Intraoperative predictors of long-term outcomes after radiofrequency endometrial ablation. J. Minim. Invasive Gynecol. 2016;23:582–589.
    1. Wishall K.M., Price J., Pereira N., Butts S.M. Postablation risk factors for pain and subsequent hysterectomy. Obstet. Gynecol. 2014;124:904–910.
    1. Shamonski M.I., Ziegler W.F., Badger G.J., Sites C.K. Prediction of endometrial ablation success by preoperative findings. Am. J. Obstet. Gynecol. 2000;182:1005–1007.
    1. Phillips G., Chien P.F., Garry R. Risk of hysterectomy after 1000 consecutive endometrial laser ablations. Br. J. Obstet. Gynaecol. 1998;105:897–903.
    1. Glasser M.H., Zimmerman J.D. The HydroThermAblator system for management of menorrhagia in women with submucous myomas; 12- to 20- month follow-up. J. Am. Assoc. Gynecol. Laparosc. 2003;10:521–527.
    1. Skensved H. Combining paracervical block with a complete fundal block significantly reduces patient's perception of pain during radio-frequency endometrial ablation in an office setting. J. Minim. Invasive Gynecol. 2015;22:S45.
    1. Chapa H.O., Venegas G., Antonetti A.G., Van Duyne C.P. In-office endometrial ablation using a third-generation uterine balloon therapy system: 12-month prospective follow-up on menstrual patterns and dysmenorrhea impact. J. Reprod. Med. 2009;54:678–684.
    1. Chapa H.O., Venegas G., VanDuyne Suvunrungsi L. In-office thermachoice III ablation: a comparison of two anesthetic techniques. Gynecol. Obstet. Investig. 2010;69:140–144.
    1. Penninx J.P., Herman M.C., Kruitwager R.F., Ter Haar A.J. Bipolar versus balloon endometrial ablation in the office: a randomized controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016;196:52–56.
    1. (07 May 2017). Queried 5/7/17.
    1. (07 May 2017). Queried 5/7/17.
    1. Munro M.G., Critchley H.O., Broder M.S., Fraser I.S., FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int. J. Gynaecol. Obstet. 2011;113:3–13.
    1. Committee on Practice Bulletins Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet. Gynecol. 2013;122:176–185.
    1. Smithling K.R., Savella G., Baker C., Matteson K.A. Preoperative uterine bleeding pattern and risk of endometrial ablation failure. Am. J. Obstet. Gynecol. 2014;211(556) (E1-6)
    1. Hokenstad A.N., El-Nashar S.A., Khan Z., Hopkins M.R. Endometrial ablation in women with abnormal uterine bleeding related to ovulatory dysfunction: a cohort study. J. Minim. Invasive Gynecol. 2015;22:1225–1230.
    1. Peeters J.A., Penninx J.P., Mol B.W., Bongers M.Y. Prognostic factors for success of endometrial ablation in the treatment of menorrhagia with special reference to previous cesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013;167:100–103.
    1. Bongers M.Y., Mol B.W., Brolmann H.A. Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia. Obstet. Gynecol. 2002;99:1060–1066.
    1. Madsen A.M., El-Nashar S.A., Hopkins M.R., Khan Z. Endometrial ablation for the treatment of heavy menstrual bleeding in obese women. Int. J. Gynaecol. Obstet. 2013;121:20–23.
    1. Thomassee M.S., Curlin H., Yunker A., Anderson T.L. Predicting pelvic pain after endometrial ablation: which preoperative patient characteristics are association? J. Minim. Invasive Gynecol. 2013;20:642–647.
    1. AlHilli M.M., Wall D.J., Brown D.L., Weaver A.L. Uterine ultrasound findings after radiofrequency endometrial ablation: correlation with symptoms. Ultrasound Q. 2012;28:261–268.
    1. Gimpelson R.J., Kaigh J. Endometrial ablation repeat procedures. Case studies. J. Reprod. Med. 1992;37:629–635.
    1. MacLean-Fraser E., Penava D., Vilos G.A. Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations. J. Am. Assoc. Gynecol. Laparosc. 2002;9:175–177.
    1. Hansen B.B., Dreisler E., Sorensen S.S. Outcome of repeated hysteroscopic resection of the endometrium. J. Minim. Invasive Gynecol. 2008;15:704–706.
    1. Garry R., Shelley-Jones D., Mooney P.L., Phillips G. Six hundred endometrial laser ablation. Obstet. Gynecol. 1995;85:24–29.
    1. . Queried 5/15/17.
    1. Sabbah R., Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J. Minim. Invasive Gynecol. 2006;13:457–471.
    1. McCausland A.M., McCausland V.M. Partial rollerball endometrial ablation: a modification of total ablation to treat menorrhagia without causing complications from intrauterine adhesions. Am. J. Obstet. Gynecol. 1999;180:1512–1521.
    1. Litta P., Nappi L., Flori P., Mencaglia L. Proposal of a modified transcervical endometrial resection (TCER) technique for menorrhagia treatment. Feasibility, efficacy and patient's acceptability. Gynecol. Surg. 2014;11:165–171.
    1. Baskett T.F., Cough H., Scott T. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases. J. Obstet. Gynaecol. Can. 2005;27:473–476.
    1. Papadakis E.P., El-Nashar S.A., Laughlin-Tommaso S.K., Shazly S.A., Hopkins M.R., Breitkopt D.M., Famuyide A.O. Combined endometrial ablation and levonorgestrel intrauterine system use in women with dysmenorrhea and heavy menstrual bleeding: novel approach for challenging cases. J. Minim. Invasive Gynecol. 2015:1203–1207.
    1. Vaughan D., Byrne P. An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) combined with endometrial ablation in the management of menorrhagia. J. Obstet. Gynaecol. 2012;32:372–374.
    1. Sohn B., Vilos G.A., Vilos A.G., Ternamian A., Abu-Rafea B., Oraif A. Resectoscopic rollerball endometrial ablation and concomitant levonorgestrel-releasing intrauterine system in women with abnormal bleeding: is the combination better? J. Minim. Invasive Gynecol. 2013;20:S69.
    1. McLucas B. Intrauterine applications of the resectoscope. Surg. Gynecol. Obstet. 1991;172:425–431.

Source: PubMed

3
Abonner